Aplysiatoxins have been shown to act as protein kinase C (PKC) activators and potent tumor promoting compounds [11,12,13,14,15]; their toxicity results from their high PKC activation potency [11,12,13,14,15]. Here, PRRT2 is linked to neoplasm.